Abbott Laboratories, Inc. ABT recently announced the receipt of the FDA approval for the i-STAT TBI (traumatic brain injury) cartridge. The test runs on Abbott's portable i-STAT Alinity instrument, ...
The test, run on Abbott (ABT)'s portable i-STAT ® Alinity ® instrument, uses whole blood to help evaluate patients with a suspected mild traumatic brain injury (mTBI), or concussion The test produces ...
The study concluded that elevated levels of two proteins help predict how a person will recover from a traumatic brain injury (TBI), providing important information to determine appropriate care ...
VANCOUVER, British Columbia, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a non-exclusive, ...
The i-STAT TBI blood test is transforming traumatic brain injury (TBI) assessment, especially for sports-related concussions. The test, developed by Abbott along with the U.S. Department of Defense, ...
The test can be used to evaluate patients up to 24 hours after injury. The Food and Drug Administration (FDA) has cleared the i-STAT ® TBI cartridge for use with whole blood to aid in the evaluation ...
The NFL could soon have a new way of diagnosing players for head injuries as the FDA has approved a new rapid concussion blood test that might make it to the sidelines. The i-STAT Alinity test can ...
ABBOTT PARK, Ill., April 1, 2024 /PRNewswire/ -- Abbott's i-STAT TBI cartridge has received clearance from the U.S. Food and Drug Administration (FDA) to be used with whole blood, allowing doctors to ...
Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. Avricore Health NewsMORE Related Stocks Indices Commodities Currencies Stocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results